Detailed Information on Publication Record
2020
The therapeutic effect of B-type natriuretic peptides in acute decompensated heart failure
CAPRNDA, Martin, Anthony ZULLI, Haaris A. SHIWANI, Peter KUBATKA, Slavomira FILIPOVA et. al.Basic information
Original name
The therapeutic effect of B-type natriuretic peptides in acute decompensated heart failure
Authors
CAPRNDA, Martin (703 Slovakia), Anthony ZULLI (36 Australia), Haaris A. SHIWANI (826 United Kingdom of Great Britain and Northern Ireland), Peter KUBATKA (703 Slovakia), Slavomira FILIPOVA (703 Slovakia), Vanda VALENTOVA (703 Slovakia), Katarina GAZDIKOVA (703 Slovakia), Ioana MOZOS (642 Romania), Andrius BERUKSTIS (440 Lithuania), Aleksandras LAUCEVICIUS (440 Lithuania), Ivan ŘIHÁČEK (203 Czech Republic, belonging to the institution), Jozef DRAGASEK (703 Slovakia), Robert PROSECKY (203 Czech Republic), Emmanuel E. EGOM (124 Canada), Robert STAFFA (203 Czech Republic, belonging to the institution), Peter KRUŽLIAK (703 Slovakia, guarantor, belonging to the institution) and Vladimir KRASNIK (703 Slovakia)
Edition
Clinical and Experimental Pharmacology and Physiology, Australia, Blackwell Publishing Australia, 2020, 0305-1870
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30104 Pharmacology and pharmacy
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 2.557
RIV identification code
RIV/00216224:14110/20:00116163
Organization unit
Faculty of Medicine
UT WoS
000520715900001
Keywords in English
B-type natriuretic peptide; clinical effectiveness; heart failure; pharmacotherapy
Tags
International impact, Reviewed
Změněno: 10/8/2020 10:35, Mgr. Tereza Miškechová
Abstract
V originále
B-type natriuretic peptide (BNP) exhibits roles in natriuresis and diuresis, making it an ideal drug that may aid in diuresing a fluid-overloaded patient with poor or worsening renal function. Several randomized clinical trials have tested the hypothesis that infusions of pharmacological doses of BNP to acute heart failure (HF) patients may enhance decongestion and preserve renal function in this clinical setting. Unfortunately, none of these have demonstrated beneficial outcomes. The current challenge for BNP research in acute HF lies in addressing a failure of concept and a reluctance to abandon an ineffective research model. Future success will necessitate a detailed understanding of the mechanism of action of BNP, as well as better integration of basic and clinical science.